Improving Treatment Outcomes of Patients With Waldenstrom Macroglobulinemia

STATEMENT OF NEED Waldenstrom macroglobulinemia (WM) is a rare lymphoproliferative disorder characterized by lymphoplasmacytic bone marrow infiltration and the presence of serum monoclonal IgM. With an estimated 1,500 new cases reported in the United States annually, the malignancy accounts for 2% of non-Hodgkin lymphomas. Unfortunately, WM is considered incurable with available therapies. Patients with low- and intermediate-risk disease have 5-year survival rates of 87% and 68%, respective...
i3 Health

Medical Spanish For the Healthcare Professional

Overview / Abstract: The Spanish speaking population has grown tremendously over the past few decades and healthcare providers in many areas of the country are challenged to communicate with this expanding patient population.The goal of this conference is to teach basic, intermediate and advanced Medical Spanish language skills in the classroom and to implement the usage of these skills with native Spanish speakers in an immersion setting. At the conclusion of this conference, participants s...
University of North Texas Health Science Center

The New Paradigm in Atopic Dermatitis Treatment

Steven Feldman, MD, PhD, and Jonathan Silverberg, MD, PhD, MPH, provide their clinical insights into the burden of disease experienced by persons with atopic dermatitis and strategies for management. They discuss how improved understanding of pathophysiologic mechanisms has led to the availability of new topical and systemic therapies that, when integrated with other therapies, can reduce patients’ disease burden. They also discuss 6 medications in late-stage development for atopic dermatitis.
Annenberg Center for Health Sciences at Eisenhower

Food Allergy: From Primary Prevention to Treatment and Intervention

This live course will allow participants to increase their knowledge and skills related to the diagnosis and management of food allergic patients. It will highlight the latest evidence related to food allergies, and will include a combination of lectures, small group discussions, and hands-on training to prepare participants to return to their practices prepared to provide optimal care to these patients. Cost varies by attendee type. See the website for details.
American Academy of Allergy, Asthma & Immunology

Implementing New Data and Evolving Standards in Metastatic Triple-Negative Breast Cancer

STATEMENT OF NEED Breast cancer accounts for approximately 30% of cancer diagnoses among women in the United States and is the second-leading cause of cancer death in this population. About 20% of patients have invasive triple-negative breast cancer (TNBC), which is defined as having estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) negativity. Whereas therapies targeting these receptors have demonstrated efficacy in other breast cancer ...
i3 Health

Challenges and Opportunities in Metastatic Gastric Cancer

STATEMENT OF NEED Gastric cancer is the third leading cause of cancer-related death worldwide. In the US, an estimated 27,510 new cases of gastric cancer are diagnosed annually, and 11,140 people die of the disease. Despite advances in prevention, diagnosis, and treatment, due to the molecular heterogeneity of gastric cancer, prognosis remains poor. The 5-year survival rate for all stages is 31%, with only 5% of those diagnosed with distant-stage disease surviving longer than 5 years. Given...
i3 Health

Medical Spanish For the Healthcare Professional

Overview / Abstract: The Spanish speaking population has grown tremendously over the past few decades and healthcare providers in many areas of the country are challenged to communicate with this expanding patient population.The goal of this conference is to teach basic, intermediate and advanced Medical Spanish language skills in the classroom and to implement the usage of these skills with native Spanish speakers in an immersion setting. At the conclusion of this conference, participants s...
University of North Texas Health Science Center

Emerging Concepts in the Recognition and Management of SLE

Michelle Petri, MD, MPH, and Daniel J. Wallace, MD, FACP, MACR, provide their experience and insight into the diagnosis and management of systemic lupus erythematosus (SLE), with perspectives for both general practitioners and rheumatologists. CONTENT AREAS • Signs and symptoms • Diagnosis • Organ-threatening disease • Non-organ-threatening disease • Treatment goals • Adherence and monitoring • Prognosis • Research topics • Clinical trials
Annenberg Center for Health Sciences at Eisenhower

Challenges and Opportunities in Hodgkin Lymphoma

STATEMENT OF NEED Hodgkin lymphoma (HL) is a rare malignancy involving the lymph nodes and lymphatic system, with 8,500 new cases diagnosed and accounting for 1,050 deaths each year in the United States. In contrast with other cancers whose risk increases with age, the risk for HL increases in patients between 15 and 30 years of age, decreases during middle age, and is followed by another peak in adults older than 55. There are 2 main types of HL: classical HL, which accounts for 95% of cas...
i3 Health

Current Trends in the Management of Castration-Resistant Prostate Cancer

STATEMENT OF NEED Prostate cancer is the most common tumor type in men in the United States. Typically, androgen deprivation therapy is administered for progressive disease. However, castration resistance or unresponsiveness to androgen deprivation therapy or to antiandrogens frequently develops over time. The transition from castration-sensitive to castration-resistant disease has yet to be understood and represents a significant unmet need. Nonmetastatic castration-resistant prostate canc...
i3 Health

Current Challenges and New Opportunities in Follicular Lymphoma

STATEMENT OF NEED Of the estimated 74,680 new cases of non-Hodgkin lymphoma each year in the United States, approximately 35% are follicular lymphoma (FL), an indolent, difficult-to-treat B-cell malignancy. Most patients are diagnosed at an average age of 65 years. Despite the introduction of novel therapies during the past decade, complications such as delayed presentation and treatment and evolving disease subtypes continue to hamper patient outcomes, and multiple recurrences with availab...
Postgraduate Institute for Medicine and i3 Health

Latest Development and Expert Outlook of Management of Psoriatic Arthritis

Psoriatic arthritis (PsA) is a chronic, inflammatory, musculoskeletal, disabling disease, commonly associated with skin psoriasis, and estimated to affect up to 42% of the approximately 7.5 million people in the United States with psoriasis. There remains an ongoing challenge among clinicians to diagnose and treat patients, as well as to stay abreast of optimal treatment strategies. In this educational program, the latest biologic treatment recommendations are reviewed, as well as clinica...
Annenberg Center for Health Sciences at Eisenhower

The Why and How for Combination Basal Insulin + GLP-1RA Therapy in Type 2 Diabetes

John Anderson, MD, and Vivian Fonseca, MD, provide their clinical insights into the rapidly evolving use of combined basal insulin and glucagon-like peptide-1 receptor agonist (GLP-1RA) therapy for the treatment of patients with type 2 diabetes mellitus (T2DM). CONTENT AREAS • Unmet needs • Experience with basal insulin/GLP-1RA • FRC basal insulin/GLP-1RAs • Insulin degludec/liraglutide (DUAL) • Insulin glargine/lixisenatide (LixiLan-L, -O) • Using FRC basal insulin/GLP-1RAs...
Annenberg Center for Health Sciences at Eisenhower

Current Trends and Future Directions in Targeted Therapies for Advanced Renal Cell Carcinoma

STATEMENT OF NEED Based on recent estimates, kidney cancer accounts for approximately 4% of all cancer diagnoses in the United States. An estimated 65,300 new cases are reported each year and more than 14,000 people die of the disease. Renal cell carcinoma (RCC), which comprises nearly 90% of all kidney cancers, is characterized by a lack of early warning signs, diverse clinical manifestations, and resistance to radiation and chemotherapy. As a result of its often asymptomatic presentation,...
Penn State College of Medicine and i3 Health

Optimizing the Management of Advanced Cervical Cancer With Checkpoint Inhibitor Therapy

STATEMENT OF NEED There are an estimated 13,240 new cases of cervical cancer in the United States each year, and 4,170 people die of the disease. Due to screening and heightened awareness, deaths have declined during the past few decades. However, the malignancy continues to be a global health concern and is considered an epidemic in parts of the world. A significant proportion of patients develop advanced disease, which is rarely curable with available therapies, and treatment is often lim...
Postgraduate Institute for Medicine and i3 Health

Idiopathic Pulmonary Fibrosis: Navigating a Complex Disease in an Evolving Treatment Landscape

Steven D. Nathan, MD, discusses how idiopathic pulmonary fibrosis (IPF) differentiates from other interstitial lung diseases. Dr. Nathan presents the impact of an early and accurate diagnosis of IPF, common symptoms, and the diagnostic tools and criteria used for an accurate diagnosis. In addition, Dr. Nathan reviews the significance of high-resolution computed tomography (HRCT) and what IPF looks like on HRCT scans. Dr. Nathan provides his insights on current treatment options and therapeutic...
Annenberg Center for Health Sciences at Eisenhower

Inject-Safe Barrier Bandages

This 1-minute (non-accredited) short-course provides training on Inject-Safe Barrier Bandages and how they prevent the transfer of bloodborne pathogens. Inject-Safe Barrier bandages self-seal to contain bleeding following an injection or immunization protecting the patient and healthcare provider. They meet the OSHA Bloodborne Pathogen Standard's definition on "Engineering Control" to reduce employee exposure.
COREreadiness

An Introduction to Pharmacogenomics (PGx)

This 15-minute (non-accredited) short-course provides a brief introduction to the study of pharmacogenomics (PGx) and its importance in pharmacotherapy. Presented by Dr. David Kisor, PharmD, FCP, Manchester University.
COREreadiness

Evaluating 503B Outsourcing Providers

This 10-minute course (non-accredited) provided by LDT Health Solutions serves to develop an understanding of the 2017 regulatory landscape as it relates to evaluating 503B outsourcing providers. This course is recommended to anyone currently in process of assessing 503B services. Content is provided by LDT Health Solutions: Lou Diorio RPh, FaPhA and Dave Thomas, RPh, MBA.
COREreadiness

Spanish for Pharmacists

A comprehensive course for pharmacists and pharmacy technicians to learn basic Spanish language skills to improve their patient counseling and communication skills in a pharmacy. Spanish for Pharmacists provides education on pharmacy "one liners", tips to communicate with Spanish speaking patients, alphabet, punctuation, general vocabulary, numbers, colors, and more!
COREreadiness

Cardinal Health: The Innovative Delivery Solutions Group | An Overview

This short course provides an overview of the various products, services, and career opportunities available with Cardinal Health Innovative Delivery Solutions or IDS. The course contains information on pharmacy management, remote order entry, and telepharmacy. As well as insights right from the Talent Acquisition Manager at Cardinal Health IDS.
COREreadiness

Actemra (tocilizumab) | Administration

This 4-minute (non-accredited) short-course on Actemra (tocilizumab) administration provides patient-facing counseling information while demonstrating patient counseling technique. It is intended for healthcare students and practitioners (pharmacy, nursing, medical, allied health) to improve patient counseling and patient communication skills. Counseling information includes: how to administer the medication and proper technique.
COREreadiness

Benlysta (belimumab) | Patient Counseling & Communication

A 3-minute (non-accredited) short-course on Benlysta (belimumab) | This course provides patient-facing counseling information while demonstrating patient counseling technique. It is intended for healthcare students and practitioners (pharmacy, nursing, medical, allied health) to improve patient counseling and patient communication skills. Counseling information includes: drug indications, dosing, and common side effects.
COREreadiness

Carvedilol | Patient Counseling & Communication Skills

A 3-minute (non-accredited) short-course on Carvedilol | This course provides patient-facing counseling information while demonstrating patient counseling technique. It is intended for healthcare students and practitioners (pharmacy, nursing, medical, allied health) to improve patient counseling and patient communication skills. Counseling information includes: drug indications, dosing, and common side effects.
COREreadiness

Insulin U-100 Vials | Administration

A 3-minute (non-accredited) short-course on Insulin U-100 Vials Administration. Providing patient-facing counseling information while demonstrating patient counseling technique. It is intended for healthcare students and practitioners (pharmacy, nursing, medical, allied health) to improve patient counseling and patient communication skills. Counseling information includes: how to administer the medication and proper technique.
COREreadiness

CareerEDGE | Interview Preparation & Advice provided by Pharmacy Recruiters

This 33-minute course (non-accredited) provides interview preparation and career advice for pharmacy students and pharmacy tech students provided by actual pharmacy recruiters throughout various practice settings (community, health system, academia, and pharma)! Learn tips on what to do in an interview, what not to do, qualities they are looking for, commonly asked questions, and more.
COREreadiness

340B Drug Pricing Discount Program | An Overview

This 1-minute (non-accredited) short-course provides an overview of the 340B Drug Pricing Discount Program. It is a ten minute, need-to-know overview of this topic for pharmacy students, tech students, and professionals to gain a working knowledge of 340B - who developed the program, which health systems qualify for the program, and how it impacts patients.
COREreadiness

The Pharmacy Experience | A Comprehensive Overview of the Pharmacy Market

A ten-hour, 68 module course (non-accredited) serving as an introduction to the pharmacy market and perfect for pharmacy students, pharmacy tech students, professionals new to the pharmacy market, and practitioners. The Pharmacy Experience course explores critical need-to-know subjects, practice settings, roles in a pharmacy, services, and pharmacy technology.
COREreadiness

Diagnosis and Natural History of Peanut Allergy

This is an interactive course that provides information about the diagnosis and natural history of peanut allergy. We will cover a variety of topics that are important when evaluating a patient for peanut allergy, such as details about testing and interpreting the results. We'll also cover pertinent information about persistence and resolution of peanut allergy.
American Academy of Allergy, Asthma & Immunology

Virtual Patient: Prescribing and Adjusting Doses for Effective AIT Treatment

In this simulation, you will see a patient who hopes immunotherapy may treat her long-standing allergy symptoms. You will be asked to provide thorough explanations of different AIT options and their risks and then write an accurate prescription based on the diagnostic tests you have run. You will monitor her progress over a period of time and make adjustments to her immunotherapy doses as needed. Just like in your clinic, you will want to make the correct decisions so that the treatments you i...
American Academy of Allergy, Asthma & Immunology

Virtual Patient: Adult Male with Reaction to Flying Hymenoptera Sting

This patient simulation involves an adult male who had a severe reaction to a flying hymenoptera sting. Based on the clinical history and test results, the learner will choose the best way to treat the patient with immunotherapy. The learner will answer specific questions that explain the immunotherapy treatment, including risks, intervals, duration, and possibility of relapse to the patient. The learner will receive feedback for each decision that is made, and numerous references that discuss...
American Academy of Allergy, Asthma & Immunology

Virtual Patient: Young Child with Allergy to Grass Pollen

This course provides a case simulation that involves evaluation and management of a young child with seasonal allergic rhinitis with allergen immunotherapy (AIT). The benefits and risks of AIT in general in the context of a young child will be reviewed, and a summary of AIT literature supporting best practices will be provided.
American Academy of Allergy, Asthma & Immunology

Eosinophilic Esophagitis from the Allergist's Perspective

This is an interactive course that aims to ensure that allergists and allied health providers understand Eosinophilic Esophagitis (EoE). The course discusses the characteristics, symptoms, and triggers of EoE and explains how it is different from other allergic reaction diseases. Diagnostic and management strategies, including diets and medications, are also covered at length.
American Academy of Allergy, Asthma & Immunology

Preventing Residual Neuromuscular Blockade and Ensuring Complete Recovery: A Discussion and Demonstration Using Simulation

Upon completion of this activity, participants will have improved their ability to: 1. Identify patients at risk for residual neuromuscular blockade (RNMB) 2. Appraise the roles of subjective and objective train-of-four monitoring in reducing the risk of RNMB 3. Employ an appropriate RNMB reversal agent and dose in patients with comorbid conditions 4. Discuss strategies to improve perioperative patient safety for moderate and deep neuromuscular blockade
Applied Clinical Education

Critical Care Medical Symposium

This course is designed for pulmonary and critical care physicians, anesthesiologists, emergency medicine physicians and other physicians who treat critically ill patients. Objectives: Recognize the long-term complications of critical illness Examine evidence-based guidelines for treating pain, agitation and delirium Review the pretransplant management of liver failure Update on the current advances in the field of extracorporeal liver support Describe the most current evidence for the e...
Medical College of Georgia

Gastroenterology & Hepatology Conference

Continuing Education Company (CEC) has been organizing its Primary Care CME Conference Series for the past 26 years. These conferences are designed to update primary care clinicians in rapidly changing therapeutic areas. The emphasis is on practical and useful information for clinical practice. As part of this series, the inaugural Gastroenterology and Hepatology Conference will be held in Orlando, Florida at the Loews Portofino Bay Hotel on January 24-26, 2020. This conference, which has been...
Continuing Education Company

Current Concepts in Joint Replacement® (CCJR) - SPRING 2020 - A Continuing Medical Education Program

Current Concepts in Joint Replacement® (CCJR) is a unique educational format that has contributed to the education of thousands of orthopaedic surgeons around the world over the last three decades. An international faculty consisting of contemporary thought leaders discuss topics related to hip, knee and shoulder arthroplasty. Each meeting is recorded in its entirety and placed on the CCJR website for future reference to assist in providing the highest possible standard of care for orthopaedi...
Current Concepts Institute

WEST COAST CULINARY THEMED CRUISE: Medical/Dental Health and Well-Being Updates

West Coast Culinary Themed Cruise on Windstar: Medical/Dental Health and Well–Being Updates San Diego to Vancouver on Windstar Star Breeze May 5 – 15, 2020 Medical/Dental Health and Well–Being Updates CME/CE Lecture Seminars for Medical, Dental, Nursing and Allied Healthcare Professionals This Seminar is planned for 14 Continuing Education Credit Hours. Seminar Overview/Statement of Purpose: Healthcare practitioners in the United States are currently faced with the challenges ...
Professional Education Society

Best Practices in Communicating About Sexual Health: What's Your Style?

Part 1: Video-Based Program - Best Practices in Communicating About Sexual Health: What's Your Style? Compare and contrast patient-clinician interactions What is your patient not telling you? Tools, tips, and conversation-starters to avoid stigma and optimize engagement
Integritas Communications

Preventing HIV Infection With PrEP: Manage This Patient

Part 2: Case-Based Program - Manage This Patient: Preventing HIV Infection With PrEP Assessing HIV risk and PrEP eligibility Pre-PrEP testing and initiation of treatment On-treatment monitoring and adherence/risk-reduction counseling
Integritas Communications

Clearing the Air in Severe Asthma Management: Improving Patient Outcomes Through Shared Clinical Decision Making

An outsized proportion of asthma-related morbidity and mortality is borne by the 5% to 15% of affected patients who have severe forms of the disease.1,2 These patients suffer from poorly controlled symptoms and frequent exacerbations, often despite daily treatment with high-dose inhaled corticosteroids and other long-acting controller medications.1,2 Ongoing research has elucidated key pathophysiologic processes and other clinical parameters related to asthma severity and persistence.2,3 In ma...
Integritas Communications

HCV Updates and Insights: Realities, Challenges, and Opportunities to Improve Care

We, in the correctional community, have a critical part to play in shaping health care delivery and advocating for our patients. This is especially pertinent to HCV care, in which significant gaps in testing, treatment, prevention, and education persist—both behind bars and upon community reentry. Across the corrections-based HCV-care continuum, providers are faced not only with challenges, but also with opportunities and options. This CorrectCare InPractice/InContext™ HCV supplement is in...
Integritas Communications

HIV Updates and Insights: Realities, Challenges, and Opportunities to Improve Care

We, in the correctional community, have a critical part to play in shaping health care delivery and advocating for our patients. This is especially pertinent to HIV care, in which significant gaps in treatment and prevention persist—both behind bars and upon community reentry. Across the corrections-based HIV-care continuum, from testing to harm-reduction practices to sustained viral suppression, providers encounter not only challenges, but also opportunities. This CorrectCare inPractice/inC...
Integritas Communications

Practical Recommendations and Demonstrations: Module 2

Chronic pain affects 100 million Americans. Certain patients with chronic pain are candidates for intrathecal (IT) therapy, which can mitigate some of the risks associated with systemic opioids. Following appropriate patient selection based on medical and psychiatric history and a physical exam, a patient can begin a trial with morphine or ziconotide, the 2 US Food and Drug Administration (FDA)–approved IT therapies. Monitoring for adverse events should continue after IT pump implantation, a...
Integritas Communications

Intrathecal Therapy for Severe Chronic Pain: Evidence-Based Recommendations: Module 1

Chronic pain affects 100 million Americans. Certain patients with chronic pain are candidates for intrathecal (IT) therapy, which can mitigate some of the risks associated with systemic opioids. Following appropriate patient selection based on medical and psychiatric history and a physical exam, a patient can begin a trial with morphine or ziconotide, the 2 US Food and Drug Administration (FDA)–approved IT therapies. Monitoring for adverse events should continue after IT pump implantation, a...
Integritas Communications

Clinical Issues™ in Chronic Liver Disease: Hot Topics in HBV, HCV, and NASH

Three chronic diseases of the liver – HCV infection, HBV infection, and NASH – are commonly managed by gastroenterologists and hepatologists. Despite the availability of safe and effective treatments for HCV, many chronically infected patients remain unscreened, undiagnosed, and untreated.1 People who inject drugs (PWID) represent a population in particular need of recognition, diagnosis, and treatment; the path to HCV elimination will never be clear without targeting PWID.2 Managing event...
Integritas Communications

PrEP U™: HIV-Prevention Education for University Student Health Centers

PrEP U™: HIV-Prevention Education for University Student Health Centers is a comprehensive professional and lay-leadership training program to help you meet the health needs of your university community. This online enduring activity for professionals from university health centers seeks to help participants understand the changing landscape of HIV in the southeast, particularly among the university community, and implement comprehensive HIV-prevention strategies. Topics to be covered includ...
Integritas Communications

The Big (& Small) Picture of NASH: Building Your Understanding to Combat a Growing Problem

Nonalcoholic steatohepatitis (NASH), part of the nonalcoholic fatty liver disease (NAFLD) spectrum, is characterized by steatosis, lobular inflammation, hepatocyte ballooning, and varying degrees of fibrosis.1 Both obesity and diabetes play large roles in development and progression of NAFLD and NASH, and the growing prevalence of NAFLD and NASH parallel the rise in obesity and diabetes.2 In addition to obesity and diabetes, multiple comorbidities occur with NASH; the 2 comorbidities that are ...
Integritas Communications

Pathways to Better Outcomes in Systemic Lupus Erythematosus: Translating Pathophysiology into Targeted Treatments

SLE is a chronic, autoimmune disorder that can present with a variety of clinical manifestations, commonly including arthritis, fever, photosensitivity, and malar rash.1,2 The disease is pathologically characterized by generalized, multisystem inflammation and the presence of a number of potential autoantibodies and immune complexes.2,3 Scientific and clinical research on SLE has uncovered factors that contribute to the characteristic loss of immune self-tolerance and the development of organ ...
Integritas Communications

Biologics for Severe Asthma A Growing Treatment Class: Module 4

This CME-accredited four-part CME Snapshot™ series is intended for pulmonologists, allergists, and other specialists involved in the long-term care of patients with severe asthma. In this educational series, expert faculty will review clinical practice guidelines, discuss new approaches to therapy, and hear directly from patients with severe asthma.
Integritas Communications

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.